Skip to main content
Kenneth Stoller, MD, Psychiatry, Baltimore, MD

KennethBruceStollerMD

Psychiatry Baltimore, MD

Addiction

Professor of Clinical Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine; Director, Johns Hopkins Broadway Center for Addiction; Medical Director, Behavioral Health, Johns Hopkins Health Plans

Dr. Stoller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Stoller's full profile

Already have an account?

  • Office

    911 North Broadway
    Baltimore, MD 21205
    Phone+1 410-955-5439
    Fax+1 410-955-4769

Summary

  • Dr. Kenneth Stoller is a psychiatrist based in Baltimore, MD, specializing in addiction. He completed his medical degree and residency in psychiatry at Johns Hopkins University after earning a BS in Zoology from the University of Maryland, College Park. He has experience in chronic pain, cocaine use disorder, opioid-related disorders, general psychiatry, and counseling. Dr. Stoller has authored several publications, including studies on methadone treatment and opioid use disorder. His work has been cited multiple times. He has received various honors, including the Nyswander/Dole Award and being named a Distinguished Lifetime Fellow of the American Psychiatric Association.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Psychiatry, 1992 - 1996
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1992
  • University of Maryland, College Park
    University of Maryland, College ParkBS, Zoology (University Honors Program), Summa Cum Laude, 1988

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1995 - 2025
  • FL State Medical License
    FL State Medical License 2016 - 2018
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry
  • Addiction Medicine
    American Board of Preventive Medicine Addiction Medicine

Awards, Honors, & Recognition

  • Elected, Distinguished Life Fellow American Psychiatric Association.
  • Nyswander/Dole Award The American Association for the Treatment of Opioid Dependence, 2016
  • Nominated for “Clinical Collaboration and Teamwork Award for Clinical Excellence.” Johns Hopkins Medicine's Office of Johns Hopkins Physicians, 2015
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Office-based buprenorphine maintenance: Setting the stage for success  
    Stoller, K.B., King, V.L., Clark, M.R., Brooner, R.K., Advanced Studies in Medicine, 1/1/2006
  • DSM-III-R versus DSM-IV substance use disorders: Concordance in drug users homogeneous for chronic and severe problems  
    Stoller, K.B., King, V.L., Kidorf, M.S., Neufeld, K.S., Brooner, R.K., Addictive Disorders and Their Treatment, 1/1/2006
  • Influence of antisocial personality subtypes on drug abuse treatment response  
    King, V.L., Kidorf, M.S., Stoller, K.B., Carter, J.A., Brooner, R.K., Journal of Nervous and Mental Disease., 1/1/2001
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • A collaborative opioid prescribing (CoOP) model linking opioid treatment programs with office-based buprenorphine providers.
    Stoller, K.B., Addiction Science & Clinical Practice, 1/1/2015
  • Synthetic cannabinoid use and awareness in a drug abuse treatment clinic.
    Disney, E. Stoller, K.B., Vandrey, R., Drug & Alcohol Dependence, 1/1/2015
  • Early treatment response to a “Motivated Stepped Care” approach using LAAM: Comparison with methadone study.
    Stoller, K.B., Carter, J.A., King, V.L., Kidorf, M.S,, Brooner, R.K., American Journal on Addictions, 1/1/2003
  • Join now to see all

Lectures

  • Transforming Addiction Treatment through Innovative Models of Care: Insights from Maryland 
    Baltimore, Maryland - 1/1/2016
  • Medication Assisted Treatment: Opportunities for Community Centers. 
    San Antonio, TX - 1/1/2016
  • Increasing Office-Based Buprenorphine Availability and Efficacy through Coordination with Opioid Treatment Programs 
    Huntington Beach, California. - 1/1/2015
  • Join now to see all

Other

  • An Opioid Treatment Model Spawns Imitators 
    Christine Vestal (The Pew Charitable Trusts/Stateline), Huffington Post, Baltimore Sun, CSPAN, Chicago Tribune, LA Times, Partnership for Drug-Free Kids, Pr
    http://www.huffingtonpost.com/entry/opioid-addiction-treatment_us_5720cf65e4b0b49df6a9b96a
    1/1/2016
  • Improving MAT Access and Quality Through Collaborative Care: The CoOP Model. 
    American Psychiatric Association sponsored national webinar for SAMHSA’s Provider Clinical Support S
    1/1/2016
  • ONDCP Director Botticelli article in ATTC Messenger 

    http://www.attcnetwork.org/Botticelli%20-%20MAT%20Article%20for%20ATTC%20Messenger%2020150819%20COS%20Approved%20v3.pdf
    1/1/2015
  • Join now to see all

Press Mentions

  • During Pandemic, Maryland’s Drug Treatment Clinics Grapple with Health Safety Issues, Rising Caseloads
    During Pandemic, Maryland’s Drug Treatment Clinics Grapple with Health Safety Issues, Rising CaseloadsJuly 27th, 2020
  • Pandemic Creates Challenges, New Opportunities for Treating Patients with Substance Use Disorder
    Pandemic Creates Challenges, New Opportunities for Treating Patients with Substance Use DisorderMay 12th, 2020
  • Long Drive Times in Rural Areas May Be a Barrier to Opioid Addiction Treatment
    Long Drive Times in Rural Areas May Be a Barrier to Opioid Addiction TreatmentOctober 2nd, 2019
  • Join now to see all